Pathogenicity and virulence of Clostridium perfringens Original paper

What was reviewed?

This review examined the molecular mechanisms, toxin biology, genetic regulation, plasmid-mediated virulence, and microbiome-associated pathogenicity of Clostridium perfringens, focusing on how toxin production, degradative enzymes, sporulation, quorum sensing, and plasmid gene transfer contribute to disease development in humans and animals. The authors synthesized microbiological, genomic, and pathogenic studies demonstrating how toxin genes, regulatory networks such as the VirS/VirR two-component system and Agr-like quorum sensing, and mobile genetic elements enable C. perfringens to transition from a commensal gastrointestinal microbiome organism into a virulent pathogen causing enteritis, food poisoning, enterotoxemia, and gas gangrene. The review emphasized that virulence is driven primarily by toxin production, plasmid gene acquisition, and microbiome colonization mechanisms, which are tightly regulated by environmental signals and bacterial density-dependent signaling pathways.

Who was reviewed?

The review analyzed studies involving Clostridium perfringens strains isolated from human gastrointestinal microbiomes, infected tissues, livestock, poultry, soil, and environmental sources, including toxinotyping, genomic sequencing, toxin activity assays, and animal infection models. These studies examined strains classified into toxinotypes A through G based on toxin gene content, including strains associated with human food poisoning, antibiotic-associated diarrhea, necrotic enteritis, enterotoxemia, and gas gangrene. The reviewed research included microbiome-associated colonization studies demonstrating that C. perfringens commonly exists in the normal intestinal microbiota but becomes pathogenic when toxin-producing strains expand or acquire plasmid-encoded toxin genes.

What were the most important findings?

The review found that Clostridium perfringens pathogenicity is driven by the coordinated expression of more than 20 toxins, including alpha toxin (CPA), beta toxin (CPB), enterotoxin (CPE), NetB toxin, perfringolysin O, and epsilon toxin, which disrupt intestinal epithelial tight junctions, degrade host membranes, induce inflammation, and cause cell death through pore formation and enzymatic destruction of structural components. The diagram on page 3 illustrates how these toxins form pores in cell membranes, disrupt actin filaments, and degrade extracellular matrix structures, enabling bacterial invasion and epithelial barrier breakdown. Major microbial associations include microbiome colonization enhanced by sialidases NanI, NanJ, and NanH, which degrade host glycans and increase bacterial adhesion, nutrient acquisition, and persistence in the gastrointestinal microbiome.

The review also demonstrated that most toxin genes are carried on conjugative plasmids such as pCW3-like plasmids, allowing horizontal gene transfer and rapid virulence evolution. Genomic analysis showed that C. perfringens possesses a highly diverse pangenome, with only 12.6% core genes, reflecting extensive genetic plasticity and adaptability. Virulence gene expression is tightly regulated by quorum sensing and regulatory systems such as VirS/VirR, which detect bacterial density signals and activate toxin production. Sporulation also plays a key role in microbiome survival, as highly resistant spores allow persistence in harsh conditions and facilitate transmission through contaminated food and environmental exposure.

What are the greatest implications of this review?

This review demonstrated that Clostridium perfringens functions as both a normal microbiome organism and a highly adaptable opportunistic pathogen whose virulence depends on toxin gene acquisition, microbiome disruption, and regulatory activation of toxin production. The ability to acquire toxin genes through plasmid transfer, survive environmental stress through sporulation, and regulate virulence through quorum sensing enables rapid pathogenic expansion under favorable conditions. These findings emphasize the importance of microbiome stability, toxin gene detection, and genomic surveillance for identifying pathogenic strains. Clinicians should recognize that microbiome-associated virulence is regulated at the genetic and ecological level, highlighting the need for microbiome-targeted therapies, antimicrobial stewardship, and early diagnostic testing to prevent toxin-mediated intestinal disease and systemic infection.